Properties
Description
Branebrutinib, soluble in DMSO and ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Formula
C20H23FN4O2
Solubility
DMSO: 73 mg/mL (197.07 mM); Water: Insoluble; Ethanol: 38 mg/mL (102.58 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Branebrutinib is used to explore improved selectivity and safety profiles in BTK inhibition for autoimmune disease therapy.
